Literature DB >> 2912067

Galactocerebrosidase activity in somatic cell hybrids derived from twitcher mouse/control human fibroblasts is associated with human chromosome 17.

T A Lyerla1, J T Konola, M C Skiba, S Raghavan.   

Abstract

Somatic cell hybrids derived from twitcher mouse cells and from control human fibroblasts were selected by two different methods. One method utilized 6-thioguanine-resistant twitcher cells as a parental line and the other used neomycin-resistant control human fibroblasts as a parental line so that hybrid lines could be selected in either HAT or in G-418 medium, respectively. The hybrid lines were analyzed for galactocerebrosidase activity. Since the twitcher cell lines are deficient in galactocerebrosidase activity, the presence of this activity in these hybrid lines depends upon the presence of human chromosome contents. Both galactocerebrosidase-positive and -deficient hybrid lines were analyzed for their human chromosome contents by the use of isozyme markers. In hybrids derived from both selection methods the expression of galactocerebrosidase activity was associated with the presence of human chromosome 17 marker isozymes. This was confirmed cytogenetically by means of trypsin-banded Giemsa staining of intact human chromosome 17 in three galactocerebrosidase-positive hybrid lines.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2912067      PMCID: PMC1715402     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  14 in total

Review 1.  Parasexual approaches to the genetics of man.

Authors:  F H Ruddle; R P Creagan
Journal:  Annu Rev Genet       Date:  1975       Impact factor: 16.830

2.  A deletion involving Alu sequences in the beta-hexosaminidase alpha-chain gene of French Canadians with Tay-Sachs disease.

Authors:  R Myerowitz; N D Hogikyan
Journal:  J Biol Chem       Date:  1987-11-15       Impact factor: 5.157

3.  Normal transcription of the beta-hexosaminidase alpha-chain gene in the Ashkenazi Tay-Sachs mutation.

Authors:  B H Paw; E F Neufeld
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

4.  Assignment of the human gene for galactokinase to chromosome 17.

Authors:  K G Orkwiszewski; T A Tedesco; C M Croce
Journal:  Nature       Date:  1974-11-01       Impact factor: 49.962

5.  Molecular heterogeneity in the infantile and juvenile forms of Sandhoff disease (O-variant GM2 gangliosidosis).

Authors:  B F O'Dowd; M H Klavins; H F Willard; R Gravel; J A Lowden; D J Mahuran
Journal:  J Biol Chem       Date:  1986-09-25       Impact factor: 5.157

6.  The Twitcher mouse: an enzymatically authentic model of human globoid cell leukodystrophy (Krabbe disease).

Authors:  T Kobayashi; T Yamanaka; J M Jacobs; F Teixeira; K Suzuki
Journal:  Brain Res       Date:  1980-12-08       Impact factor: 3.252

7.  Heterogeneity in type I Gaucher disease demonstrated by restriction mapping of the gene.

Authors:  J Sorge; T Gelbart; C West; B Westwood; E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

8.  Optimal assay conditions for enzymatic characterization of homozygous and heterozygous twitcher mouse.

Authors:  S Raghavan; A Krusell
Journal:  Biochim Biophys Acta       Date:  1986-06-11

9.  Hereditary leucodystrophy in the mouse: the new mutant twitcher.

Authors:  L W Duchen; E M Eicher; J M Jacobs; F Scaravilli; F Teixeira
Journal:  Brain       Date:  1980-09       Impact factor: 13.501

10.  The human gene map. 15 November 1983.

Authors:  V A McKusick
Journal:  Clin Genet       Date:  1984-01       Impact factor: 4.438

View more
  2 in total

1.  Localization of the Krabbe disease gene (GALC) on chromosome 14 by multipoint linkage analysis.

Authors:  R Oehlmann; J Zlotogora; D A Wenger; R G Knowlton
Journal:  Am J Hum Genet       Date:  1993-12       Impact factor: 11.025

2.  Krabbe disease locus mapped to chromosome 14 by genetic linkage.

Authors:  J Zlotogora; S Chakraborty; R G Knowlton; D A Wenger
Journal:  Am J Hum Genet       Date:  1990-07       Impact factor: 11.025

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.